The U.S. Food and Drug Administration approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes.

The post FDA approves this drug to treat Parkinson’s disease appeared first on Knowridge Science Report.

…read more

Source:: Knowridge Science Report

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *